Authors: Pinheiro, JPV Lanvers, C Boos, J

Citation: Jpv. Pinheiro et al., Use of PEG-asparaginase in the treatment of patients with solid tumors, CANC CHEMOT, 48(5), 2001, pp. 421-422

Authors: Pinheiro, JPV Muller, HJ Schwabe, D Gunkel, M da Palma, JC Henze, G von Schutz, V Winkelhorst, M Wurthwein, G Boos, J

Citation: Jpv. Pinheiro et al., Drug monitoring of low-dose PEG-asparaginase (Oncaspar (TM)) in children with relapsed acute lymphoblastic leukaemia, BR J HAEM, 113(1), 2001, pp. 115-119

Authors: Muller, HJ Loning, L Horn, A Schwabe, D Gunkel, M Schrappe, M von Schutz, V Henze, G da Palma, JC Ritter, J Pinheiro, JPV Winkelhorst, M Boos, J

Citation: Hj. Muller et al., Pegylated asparaginase (Oncaspar (TM)) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols, BR J HAEM, 110(2), 2000, pp. 379-384

Authors: Pinheiro, JPV Ahlke, E Nowak-Gottl, U Hempel, G Muller, HJ Lumkemann, K Schrappe, M Rath, B Fleischhack, G Mann, C Boos, J

Citation: Jpv. Pinheiro et al., Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols, BR J HAEM, 104(2), 1999, pp. 313-320